Patient Support Helpline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Novel Polygenic Hazard Score Captures Age Variations of Aggressive Prostate Cancer

An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated... Read More

Researchers Adopt New Approach to Treating Advanced Prostate Cancer

Scientists have proposed a new approach to preventing the proliferation of prostate tumor cells that are no longer responding to... Read More

Small Protein Modification Can Trigger Invasive Properties of Prostate Cancer Cells, Research Finds

A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research... Read More

Common Genetic Fusion Event Could Help Identify Patients with Low-Risk Prostate Cancer

Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than... Read More

UTSA Professor Awarded Grant to Support Development of Prostate Cancer Detection Method

Jing Yong Ye, professor of biomedical engineering at The University of Texas at San Antonio (UTSA), has received a two-year,... Read More

Fusion Guided Biopsy Can Help with Accurate Diagnosis of Prostate Cancer

There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s... Read More

New Diagnostic Test Uses Machine Learning to Accurately Detect Aggressive Prostate Cancer

A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer.... Read More

Prolaris Becomes First Genetic Test to Receive Medicare Coverage for Favorable Intermediate and Low-Risk Prostate Cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor... Read More

Addressing Unmet Needs in Prostate Cancer

An interview with Dr. Catherine Taylor, Therapy Area Lead Haematology, Janssen EMEA conducted by April Cashin-Garbutt, MA (Cantab) Read more.

Family History Does Not Appear to Increase Risk of Prostate Cancer Progression, Analysis Reveals

A recent analysis of the medical literature concluded that a family history of prostate cancer does not appear to increase... Read More

1 2 3 4 5 6